The Discounted Cash Flow (DCF) valuation of Regenxbio Inc (RGNX) is (90.02) USD. With the latest stock price at 8.53 USD, the upside of Regenxbio Inc based on DCF is -1155.3%.
Based on the latest price of 8.53 USD and our DCF valuation, Regenxbio Inc (RGNX) is a sell. selling RGNX stocks now will result in a potential gain of 1155.3%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.6% - 8.5% | 7.1% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (451.57) - (52.68) | (90.02) |
| Upside | -5393.9% - -717.6% | -1155.3% |